Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-21

Clinical Trial Update: Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing patient preferences for AZARGA versus COSOPT in glaucoma patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azarga (brinzolamide; timolol maleate)
  • Cosopt (dorzolamide/timolol)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED